Event Partners

• 
• 
• 
• 

This panel assembles established investors and entrepreneurs, many of whom have been on both sides of the conversation of founding ideas and investing in their growth. What connects emerging research to regional angel networks, and beyond? What are the different pathways required to develop a $50,000 medical app versus the $100,000,000 lifetime raise to bring a drug to market?

This panel examines the unique challenges surrounding IP as it emerges from research institutions like the University of Virginia, leverages non-dilutive (grant money) and networks outside of the region for that "next step."

Panelists:

• Alex Euler, Investment Director, Center for Innovative Technology (CIT)
• Andy Krouse, President and CEO of Tau Therapeutics
• Michael Straightiff, Director, U.Va. Licensing and Ventures Group
• Dr. Henry Skinner, Managing Director, Novartis Venture Fund

Featuring

• 

  Alex Euler, Investment Director, CIT

• 

  Andrew Krouse, Founder Tau Therapeutics

• 

  Michael Straightiff, Director at U.Va. Licensing &...